COVID-19

News

Celltrion trials infliximab biosimilar in recovering COVID-1...

South Korea’s Celltrion Healthcare has begun a UK trial of its infliximab biosimilar to see if the drug can accelerate recovery from symptoms of COVID-19.

News

Boehringer Ingelheim, Biberach, Germany, February 2007

Boehringer launches open innovation project for work-at-home...

Germany’s Boehringer Ingelheim is to make a bank of its molecules available to scientists in a bid to encourage open innovation during the COVID-19 pandemic, when many scientists are workin

News

Regeneron begins trials of COVID-19 antibody cocktail

Regeneron has said it has begun clinical trials of its antibody cocktail therapy for COVID-19, as pharma companies continue their search for treatments as the pandemic continues to cause ha

News

J&J brings forward start of COVID-19 vaccine trial to next m...

Johnson & Johnson has announced it has brought forward the start of its COVID-19 vaccine by around two months to mid-July.

Views & Analysis

Digital health predicted as the new normal in COVID aftermat...

There are few countries left unaffected by COVID-19 and solutions can’t seem to arrive soon enough.

News

Brexit drug stock piles 'used up' during coronavirus pandemi...

The pharma industry has warned that the UK’s stockpiles of medical supplies intended to cover disruption caused by Brexit have been “used up entirely” by the effort against the coronavirus,

Celltrion trials infliximab biosimilar in recovering COVID-1...

Boehringer launches open innovation project for work-at-home...

Regeneron begins trials of COVID-19 antibody cocktail

J&J brings forward start of COVID-19 vaccine trial to next m...

Digital health predicted as the new normal in COVID aftermat...

Brexit drug stock piles 'used up' during coronavirus pandemi...

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

COVID-19

Editor's Picks